Covaris, Caliper enter co-marketing agreement to leverage next generation sequencing

Caliper Life Sciences, Inc. (Nasdaq: CALP) and Covaris Inc., Woburn, Mass., today announced a co-marketing agreement which will leverage Covaris' acoustic DNA shearing platforms and Caliper's automation and microfluidics technologies to develop automated workflows for next generation sequencing experiments. Caliper has developed a complete suite of solutions for library construction, sample analysis, and nucleic acid fractionation, which significantly reduces manual manipulations, increases throughput and improves sample-to-sample consistency.

"Our Sciclone NGS, LabChip GX, and LabChip XT have become critical tools in leading next generation sequencing laboratories already utilizing Covaris' technology," said Kevin Hrusovsky, President and Chief Executive Officer of Caliper Life Sciences. "This collaboration is a logical next step toward simplifying workflows for scientists challenged with meeting the growing demands of next generation sequencing sample preparation. As sequencing technologies move from the lab bench to the clinic, it is critical that integrated solutions offer consistency and sample tracking."

"Covaris provides a wide variety of next-gen sample prep solutions for the evolving needs of sequencing laboratories relative to nucleic acid shearing and sample extraction," said Jim Laugharn, Covaris President and Chief Executive Officer.  "Covaris recognizes the importance of high quality sample preparation as a fundamental component for advanced life science systems, such as in Next Generation DNA Sequencing."

Covaris sample preparation technology, which is based on its industry-standard Adaptive Focused Acoustic™ (AFA) technology, brings quality, speed, and efficiency to biological and chemical sample preparation with the single-sample S220, the multi-sample E220 and high throughput parallel-processing LE220. The isothermal and non-contact Covaris method accelerates next-generation DNA sequencing sample preparation by providing a highly predictable and reproducible DNA shearing instrumentation, consumables, and applications to the next-gen workflow.

Caliper's portfolio of microfluidic and automation solutions that uniquely enable sample preparation for high throughput sequencing.  Caliper's sequencing tools include the LabChip XT for nucleic acid fractionation, the LabChip GX for library quantification and sizing, the recently launched LabChip DS for purity and quality control, the Zephyr® Genomics Workstation for automated nucleic acid extraction and reaction setup, and the Sciclone® NGS Workstation, which includes validated protocols for library preparation, sequence capture, and sample normalization. For additional information on Caliper's solutions for next generation sequencing, please visit www.caliperls.com/genomics.

SOURCE Caliper Life Sciences, Inc.